Herpes Zoster Market OverviewThe herpes zoster market is anticipated to reach USD 224 Million by 2030 at 8.90% CAGR during the forecast period 2022-2030 Currently, there are only two vaccines licensed and available in the US for shingles namely Zostavax (zoster vaccine live) and Shingrix (reco...